Project Details
Description
A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/08 → 4/23/09 |
Funding
- INSERT THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.